TNPSC Thervupettagam

2-DG oral drug

May 11 , 2021 1220 days 921 0
  • The 2-DG was developed by the Defence Research Development Organisation for Emergency Use.
  • 2-DG is 2-Deoxy – D – Glucose.
  • It was developed in collaboration with Dr Reddy’s Laboratories.
  • The DGCI has granted permission for emergency use of the drug in moderate to severe COVID-19 patients.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories